AC-93-LT43_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, US11458138, Example 133, LATS inhibitor;Yap pathway activator targeting LATS1, LATS2 (Novartis, 137350911)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/137350911
Similar Terms
Downloads & Tools

Genes

22 genes differentially expressed following the AC-93-LT43_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
KRT17 keratin 17, type I 0.633725
TAGLN transgelin 0.588569
MYEOV myeloma overexpressed 0.548774
IER3 immediate early response 3 0.547952
SNU13 small nuclear ribonucleoprotein 13 0.303542
MYL9 myosin, light chain 9, regulatory 0.303542
C5ORF46 chromosome 5 open reading frame 46 0.241453
S100A11 S100 calcium binding protein A11 0.241453
CRYAB crystallin, alpha B 0.238715
IGFL3 IGF-like family member 3 0.23179
PDLIM4 PDZ and LIM domain 4 0.23179
AMIGO2 adhesion molecule with Ig-like domain 2 0.227734
CD70 CD70 molecule 0.211233

decreased expression

Symbol Name Standardized Value
MT2A metallothionein 2A -1.10019
RRM2 ribonucleotide reductase M2 -0.680464
CPA4 carboxypeptidase A4 -0.578951
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.525149
MT1E metallothionein 1E -0.382413
STMN1 stathmin 1 -0.288731
FTL ferritin, light polypeptide -0.265905
CTDSP2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 -0.23179
PLAC8 placenta-specific 8 -0.212746